Abdominal lymphadenopathy detected by ultrasonography in HIV-1 infection: prevalence and significance.

By using abdominal ultrasonography (UlS), deep nodes were detected in 41 of 85 (48%) HIV-1 positive subjects, most of them heroin addicts, but in none of 85 healthy HIV-negative controls. Computerized tomography, performed in 10 cases of lymphadenopathy, invariably confirmed the UlS findings. Prevalence [asymptomatic carriers: 8/15 (53%); PGL patients: 8/18 (44%); ARC: 13/27 (48%); AIDS: 12/25 (48%)], number, size, and site of deep nodes were comparable among the different CDC groups. No correlation was found between abdominal and superficial lymphadenopathy. Median serum concentrations of gammaglobulins (g/dl) and IgG (mg/dl) were higher in patients with than without deep nodes (2.25 vs 1.87 and 2540 vs 1900, respectively) (p < 0.01) as well as in cases with than without superficial nodes (2.15 vs 1.80 and 2340 vs 1941, respectively) (p < 0.05). Abdominal lymphadenopathy occurred during all stages of HIV infection even in asymptomatic carriers: this should be considered in the differential diagnosis of UlS-detected deep nodes. Enlargement of either deep or superficial nodes seems to reflect a state of polyclonal B cell activation.

[1]  H. Zonderland,et al.  Evaluation of abdominal lymph nodes by ultrasound. , 1990, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[2]  M. Zoli,et al.  Prevalence and Significance of Abdominal Lymphadenopathy in Patients with Chronic Liver Disease: An Ultrasound Study , 1990, Journal of clinical gastroenterology.

[3]  Jules L. Dienstag,et al.  An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis , 1989 .

[4]  R. Vogelzang,et al.  Lymphadenopathy in chronic active hepatitis: CT observations. , 1988, AJR. American journal of roentgenology.

[5]  M B Alpern,et al.  Abdominal lymphadenopathy in benign diseases: CT detection. , 1987, Radiology.

[6]  A. Fauci,et al.  Direct polyclonal activation of human B lymphocytes by the acquired immune deficiency syndrome virus. , 1986, Science.

[7]  R. Redfield,et al.  Mechanisms of B cell activation in patients with acquired immunodeficiency syndrome and related disorders. Contribution of antibody-producing B cells, of Epstein-Barr virus-infected B cells, and of immunoglobulin production induced by human T cell lymphotropic virus, type III/lymphadenopathy-associa , 1986, The Journal of clinical investigation.

[8]  R. Jeffrey,et al.  AIDS-related lymphomas: evaluation by abdominal CT. , 1986, Radiology.

[9]  R. Redfield,et al.  Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infections. , 1986, MMWR. Morbidity and mortality weekly report.

[10]  A. Megibow,et al.  Abdominal tuberculosis: CT evaluation. , 1985, Radiology.

[11]  S. Horii,et al.  Abdominal lymphadenopathy in intravenous drug addicts: sonographic features and clinical significance. , 1985, AJR. American journal of roentgenology.

[12]  P. Volberding,et al.  Kaposi sarcoma and lymphadenopathy syndrome: limitations of abdominal CT in acquired immunodeficiency syndrome. , 1984, Radiology.

[13]  P. Ralls,et al.  Burkitt lymphoma in acquired immune deficiency syndrome. , 1984, Journal of computer assisted tomography.

[14]  A. Fauci,et al.  Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. , 1983, The New England journal of medicine.